RADIAL TO CORONARY

Why Radial to Coronary?

Transradial Artery Access (TRA) for percutaneous coronary intervention (PCI) is proven to reduce associated bleeding and vascular complications; especially in patients with acute coronary syndromes (ACS).1 Use of TRA for coronary angiography and PCI is also associated with improved measures of quality of life and reduced costs compared with Transfemoral Access. A growing body of evidence supports adoption of TRA to improve ACS-related outcomes, to improve healthcare quality, and to reduce cost.1

BENEFITS OF TIS CORONARY SOLUTIONS

Terumo Interventional systems offers a suite of products designed to meet specific challenges in treating coronary artery disease. With its radial specific offerings, Terumo provides:

  • Transradial access and closure devices that allow the operators to optimize procedural outcomes while preserving arterial function post-intervention.
  • Wires and catheters to navigate through tortuous anatomy and PTCA balloons to cross and treat complex lesions to improve outcomes.

In addition, Terumo hydrophilic coating helps reduce radial artery spasm.2 Allowing the operator to optimize procedural outcomes and patient satisfaction while preserving arterial function.

Learn more about Coronary Procedural Solutions.

RESOURCES

Coronary Artery Disease, or CAD, develops when the major blood vessels in the heart (coronary arteries) become damaged or diseased. Cholesterol-containing deposits (plaque) in arteries and inflammation are usually to blame for coronary artery disease.3 Below are a few articles demonstrating the benefit of radial access coronary procedures.

The Radial Approach for STEMI - Could this become the new standard of care?
The Advantages of Universal Guiding Catheters for the Transradial Approach.
Vascular Access, Management, and Closure: Best Practices. 2019.
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

REFERENCES

  1. Valgimigli M,MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.Lancet. 2015; 385:2465–2476.
  2. Rathore S. Impact of Length and Hydrophilic Coating of the Introducer Sheath on Radial Artery Spasm During Transradial Coronary Intervention A Randomized Study. JACC Cardiovasc Interv. 2010;3(5):475-83.
  3. CDC, NCHS. Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, released 2015. Data are from the Multiple Cause of Death Files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed Feb. 3, 2015: https://wonder.cdc.gov/wonder/help/ucd.html.